Adaptimmune Therapeutics plc (ADAP): Price and Financial Metrics

ADAP POWR Grades

• ADAP scores best on the Sentiment dimension, with a Sentiment rank ahead of 83.27% of US stocks.
• ADAP's strongest trending metric is Quality; it's been moving down over the last 177 days.
• ADAP ranks lowest in Momentum; there it ranks in the 4th percentile.

ADAP Stock Summary

• For ADAP, its debt to operating expenses ratio is greater than that reported by merely 17.2% of US equities we're observing.
• As for revenue growth, note that ADAP's revenue has grown 305.3% over the past 12 months; that beats the revenue growth of 97.91% of US companies in our set.
• In terms of volatility of its share price, ADAP is more volatile than 85.38% of stocks we're observing.
• Stocks that are quantitatively similar to ADAP, based on their financial statements, market capitalization, and price volatility, are ONTX, ABEO, SPCE, SABS, and SMR.
• ADAP's SEC filings can be seen here. And to visit ADAPTIMMUNE THERAPEUTICS PLC's official web site, go to www.adaptimmune.com.

ADAP Valuation Summary

• In comparison to the median Healthcare stock, ADAP's price/sales ratio is 50% lower, now standing at 1.8.
• Over the past 92 months, ADAP's price/sales ratio has gone down 37.4.

Below are key valuation metrics over time for ADAP.

ADAP Growth Metrics

Its 3 year net income to common stockholders growth rate is now at -66.94%.
• Its 4 year net income to common stockholders growth rate is now at -77.31%.
• Its year over year cash and equivalents growth rate is now at 146.4%.

ADAP's revenue has moved down $44,759,000 over the prior 49 months.

The table below shows ADAP's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	17.537	-9.883	-175.064
2022-06-30	11.733	-6.924	-176.044
2022-03-31	9.29	2.868	-170.592
2021-12-31	6.149	10.729	-158.09
2021-09-30	6.234	-152.415	-155.845
2021-06-30	6.224	-123.532	-148.876

ADAP's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ADAP has a Quality Grade of C, ranking ahead of 58.13% of graded US stocks.
• ADAP's asset turnover comes in at 0.016 -- ranking 378th of 682 Pharmaceutical Products stocks.
• CALA, ACOR, and INSM are the stocks whose asset turnover ratios are most correlated with ADAP.

The table below shows ADAP's key quality metrics over time.